Approval · Notice of Compliance 34983 · 2025
CODEINE CONTIN: Notice of Compliance 34983
Issued March 4, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34983
- Date
- March 4, 2025
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CODEINE CONTIN | Not yet assigned | — |
Medicinal ingredients
- CODEINE MONOHYDRATE 50 MG per TAB
- CODEINE MONOHYDRATE 100 MG per TAB
- CODEINE MONOHYDRATE 150 MG per TAB
- CODEINE MONOHYDRATE 200 MG per TAB